Suggested table of clinical case studies (to include in article): columns for patient phenotype (age, BMI, diagnosis), peptide used (dose, duration), metabolic outcomes (weight change, HOMA-IR), reproductive outcomes (ovulation, oocyte yield, pregnancy), adverse events, and follow-up duration, such as PCOS, obesity-associated anovulation, poor ovarian response, and metabolic syndrome
Scientific understanding, particularly in the context of new gene data, indicates its profound regenerative and protective actions
Side Effect Profile: advantage goes to PE-22-28
If a product is classified as a medicine and is not appropriately authorised, we are able to take action to ensure regulatory compliance, including the removal of the product from the UK market where necessary